In gastric cancer (GC), liver cancer and lung cancer, YTHDF2 was found to be both upregulated and downregulated, suggesting that YTHDF2 may play a dual role as both an oncogene and tumor suppressor [184]. This evidence concerns the gene YTHDF2 and lung carcinoma.